117 related articles for article (PubMed ID: 7037548)
1. Hydergine in senile mental impairment.
Loew DM; Weil C
Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
[TBL] [Abstract][Full Text] [Related]
2. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
3. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
Gross RJ; Eisdorfer CE; Schiller HS; Cox G
Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
[TBL] [Abstract][Full Text] [Related]
4. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
5. Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.
Rouy JM; Douillon AM; Compan B; Wolmark Y
Curr Med Res Opin; 1989; 11(6):380-9. PubMed ID: 2651014
[TBL] [Abstract][Full Text] [Related]
6. Hydergine: interaction with the neurotransmitter systems in the central nervous system.
Markstein R
J Pharmacol; 1985; 16 Suppl 3():1-17. PubMed ID: 2869188
[TBL] [Abstract][Full Text] [Related]
7. Senile dementia: combined pharmacologic and psychologic treatment.
Yesavage JA; Westphal J; Rush L
J Am Geriatr Soc; 1981 Apr; 29(4):164-71. PubMed ID: 7204812
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of hydergine in patients with Alzheimer's disease.
Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
[TBL] [Abstract][Full Text] [Related]
9. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
10. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
11. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
13. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
[TBL] [Abstract][Full Text] [Related]
15. Hydergine for schizophrenia.
Cohen MR; Pary R; Burns R
J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation in geriatric psychopharmacology. The point of view of the pharmaceutical industry].
Loew DM
Presse Med; 1983 Dec; 12(48):3141-6. PubMed ID: 6228929
[TBL] [Abstract][Full Text] [Related]
17. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
18. Hydergine effect on prolactin and reaction time in dementia.
el Sobky A; el Shazly M; Darwish AK; Davies T; Griffin K; Keshavan MS
Biol Psychiatry; 1986 Oct; 21(12):1229-30. PubMed ID: 3756269
[No Abstract] [Full Text] [Related]
19. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Biel ML; Seus R; Struppler A
Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
[TBL] [Abstract][Full Text] [Related]
20. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
Milvio C
Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
